O’Melveny has advised SciNeuro. SciNeuro Pharmaceuticals has completed a US$53 million equity financing round. The funding round was led by LAV and ARCH Venture Partners, with...
SciNeuro Secures US$53 Million in Equity Financing
CapsoVision Completes $27.5 Million Nasdaq IPO
O’Melveny has advised CapsoVision, Inc. Ellenoff Grossman & Schole LLP has advised the underwriters. CapsoVision, Inc. has completed its initial public offering and listing on the...
TXO Partners’ Acquisition of Greater Williston Basin Assets from Eagle Mountain Energy Partners
O’Melveny & Myers LLP advised Eagle Mountain Energy Partners, while Welborn Sullivan Meck & Tooley, P.C. advised TXO Partners on the deal. Eagle Mountain Energy Partners,...
Stonepeak’s $7.4 Billion Acquisition of Textainer
Simpson Thacher & Bartlett is advising Stonepeak on the transaction, and O’Melveny & Myers is advising Textainer Group Holdings Limited. Stonepeak announced it has entered into...
Beauty Farm’s Hong Kong IPO and Listing
O’Melveny advised Beauty Farm. Clifford Chance has advised the joint sponsors. Shearman & Sterling advised Beijing Xinyu Meiye Holdings Limited as a selling shareholder. Beauty Farm...
Cryofocus Medtech’s HK$210 Million IPO
Cooley advised the joint sponsors and underwriters on the deal while O’Melveny represented Cryofocus Medtech (Shanghai) Co., Ltd. Cryofocus Medtech announced its HK$210 million ($27 million) initial...
3D Medicines Inc.’s Listing on the Stock Exchange of Hong Kong
Herbert Smith Freehills advised CICC and CSCI on the deal while O’Melveny recently represented 3D Medicines. CICC and CSCI acted as joint sponsors of 3D Medicines...
Genesis Growth Tech Acquisition Corp.’s Merger with Biolog-ID
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Charles Russell Speechlys and Carey Olsen served as legal counsel to Biolog-id. O’Melveny & Myers LLP, Allen &...
Rainmed Medical’s HK$146 Million IPO and Listing on the Hong Kong Stock Exchange
O’Melveny and Grandall represented Rainmed Medical Limited (2297.HK) on the deal. Herbert Smith Freehills has advised Huatai Financial Holdings. Rainmed Medical Limited (2297.HK) announced its US$19...
Dragonfly Energy’s Business Combination with Chardan NexTech Acquisition 2 Corp.
O’Melveny & Myers, LLP and Parsons Beble & Latimer advised Dragonfly. Skadden, Arps, Slate, Meagher & Flom and Brownstein Hyatt Farber Schreck advised CNTQ. Chapman and...
Belite Bio’s $36 Million IPO
Wilson Sonsini Goodrich & Rosati and O’Melveny advised Belite Bio on the deal. Belite Bio, Inc., a clinical-stage biopharmaceutical drug development company, announced the pricing of...
Brii Biosciences’ US$318 Million Hong Kong IPO
O’Melveny & Myers and Maples and Calder advised Brii Biosciences Limited on the deal. Herbert Smith Freehills has advised Morgan Stanley and UBS. Brii Biosciences Limited...